Osteoporosis
From the Journals
Higher BMD linked to family history of diabetes in postmenopausal women
The connection may be related to insulin resistance.
From the Journals
Zoledronic acid reduces symptomatic periodontal disease in patients with osteoporosis
Coupled with good oral hygiene, the investigators suggest zoledronic acid might prevent development of osteonecrosis of the jaw.
From the Journals
Zoledronate maintains bone loss after denosumab discontinuation
The results suggest that, after achieving nonosteoporotic BMD with denosumab, a single intravenous infusion of zoledronate given 6 months after...
From the Journals
High-dose vitamin D for bone health may do more harm than good
A randomized trial showed an inverse dose-response relationship between high-dose vitamin D supplementation and bone quality in healthy adults.
From the Journals
FRAX with BMD may not be accurate for women with diabetes
Both major osteoporotic fracture and hip fracture are underestimated by FRAX with BMD in women with diabetes.
From the Journals
Self-reported falls can predict osteoporotic fracture risk
Over an almost 3-year period, about 3.5% of the population experience a major osteoporotic fracture.
From the Journals
Analysis finds no mortality reductions with osteoporosis drugs
A meta-analysis has found no evidence that osteoporosis drugs are associated with a reduction in mortality.
From the Journals
Lower BMD found in patients with severe hemophilia A
The decrease in BMD was correlated with reduced functional ability and body mass index, and vitamin D insufficiency or deficiency.
Latest News
Bisphosphonates improve BMD in pediatric rheumatic disease
Children and adolescents whose chronic rheumatic disease is treated with steroids could benefit from bisphosphonate therapy to improve bone...
From the Journals
Inadequate glycemic control in type 1 diabetes leads to increased fracture risk
Each percentage increase in hemoglobin level was associated with a 7% increase in fracture risk.
From the Journals
Cathepsin Z identified as a potential biomarker for osteoporosis
The level of cathepsin Z mRNA in PBMC preparations could form the basis of a test for osteoporosis